Curated News
By: NewsRamp Editorial Staff
September 02, 2026
Viromed Medical Appoints Prof. Dr. Michael A. Rubhausen to Medical Advisory Board
TLDR
- Viromed Medical gains a competitive edge by adding Prof. Rubhausen, a top spectroscopy expert, to its advisory board.
- Prof. Rubhausen's expertise in spectroscopy and materials research will enhance Viromed's evaluation of scientific questions.
- Viromed's new advisory board member may improve cold plasma therapies, advancing medical care.
- Viromed Medical taps a physicist who uses AI to analyze complex data, potentially unlocking new insights.
Impact - Why it Matters
This news matters because it signals Viromed Medical's strategic move to bolster its research capabilities in cold plasma technology, a field with significant potential for medical applications. The addition of a distinguished physicist like Prof. Rubhausen could accelerate the development of novel therapies, potentially leading to improved treatments and patient outcomes. For investors and industry observers, this appointment may enhance confidence in Viromed's innovative pipeline and long-term growth prospects, while also highlighting the importance of interdisciplinary collaboration in advancing medical technology.
Summary
Viromed Medical AG, a German medical technology company specializing in cold plasma technology, has announced the appointment of Prof. Dr. Michael A. Rubhausen to its Medical Advisory Board, effective immediately. The physicist, who is a renowned expert in spectroscopy and materials research, will lend his scientific acumen to help evaluate research questions at the intersection of material properties, spectroscopy, and cold plasma, thereby supporting the company's ongoing research initiatives. Uwe Perbandt, CEO of Viromed Medical AG, expressed enthusiasm about the appointment, highlighting Prof. Rubhausen's proven expertise as a valuable asset for thoroughly assessing scientific challenges and advancing the firm's research work.
Prof. Rubhausen currently heads the Optics Working Group at the Institute of Nanostructure and Solid-State Physics at Universität Hamburg, where he also serves as Managing Director. He is affiliated with the Center for Free-Electron Laser Science (CFEL) and conducts research using modern spectroscopic methods such as Raman spectroscopy and ellipsometry to study superconductors, quantum materials, and biological samples at large-scale facilities like PETRA III and FLASH. With over 180 publications and approximately 4,000 citations in prestigious journals, his interdisciplinary work also includes developing AI-supported analysis workflows for complex datasets, making him a highly qualified addition to the advisory board.
Viromed Medical AG, listed on the stock exchange since October 2022, focuses on the development, manufacture, and distribution of medical products, particularly innovative cold plasma technology through its subsidiary Viromed Medical GmbH. The company serves a broad customer base in the DACH region and beyond, aiming to advance the medical use of cold plasma and realize growth potential. This appointment underscores Viromed's commitment to strengthening its scientific foundation and accelerating innovation in this emerging field.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, Viromed Medical Appoints Prof. Dr. Michael A. Rubhausen to Medical Advisory Board
